Johnson Matthey (LON:JMAT) Hits New 52-Week Low – Here’s Why

Johnson Matthey PLC (LON:JMAT)’s share price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 1,289 ($16.63) and last traded at GBX 1,308 ($16.87), with a volume of 1724131 shares changing hands. The stock had previously closed at GBX 1,334 ($17.21).

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($23.22) price target on shares of Johnson Matthey in a research note on Tuesday, December 17th.

Johnson Matthey Price Performance

The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The stock has a market capitalization of £2.04 billion, a P/E ratio of 20.75, a PEG ratio of 49,242.50 and a beta of 0.95. The stock’s fifty day moving average is GBX 1,417.73 and its 200-day moving average is GBX 1,438.32.

Insider Transactions at Johnson Matthey

In other news, insider Liam Condon purchased 30 shares of the firm’s stock in a transaction on Wednesday, January 22nd. The stock was bought at an average cost of GBX 1,362 ($17.57) per share, for a total transaction of £408.60 ($527.09). Also, insider Stephen Oxley purchased 27 shares of the stock in a transaction dated Wednesday, February 19th. The stock was acquired at an average cost of GBX 1,451 ($18.72) per share, for a total transaction of £391.77 ($505.38). In the last quarter, insiders purchased 84 shares of company stock worth $119,052. 0.61% of the stock is owned by corporate insiders.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.